In the stock market, men's liquor and women's medical beauty is the consumer field of attention to the two major sectors, liquor industry stock prices generally have been high, while the medical beauty industry is emerging, due to the high profits, high growth rate, generally regarded as the next quality track, then the medical beauty plate which stocks?
What are the stocks in the medical beauty sector?
The A-share market is divided into two main categories of medical beauty concept stocks: one category is based on beauty equipment and consumables, such as access to LibraHealth device Xinhua Jin, hyaluronic acid concept stocks Huadong Pharmaceutical, and Shuanglu Pharmaceuticals, to provide breast tissue patch Guanhao Biological, as well as the Hong Kong stock Huaxi Biotechnology, Hao Hai Biotechnology. The other category is plastic surgery hospitals and clinics, such as Lanzi, which holds stakes in Korean plastic surgery organizations, Alloy Investment, which is expanding its beauty hospital, Fosun Pharmaceutical, which holds Israeli medical and aesthetic device companies, and new Third Board companies such as Huahan Plastic Surgery, Lidu Plastic Surgery and Limei Kang.
1 love beauty (300896): hyaluronic acid one of the three giants, the first to obtain the relevant product medical device registration certificate of the enterprise medical beauty industry leader, face value of the economic leader, focusing on the field of light medical aesthetic, the domestic bio-medical soft tissue repair materials in the field of innovative and leading enterprises.
2 Huaxi biological (688363): global hyaluronic acid raw materials leader, market share of 40%, in recent years, the power of skincare brands Runbayan, Quadi, the launch of explosive models of the Forbidden City lipstick.
3 Haohai Shengke (688366): one of the three giants of hyaluronic acid, mainly doing ophthalmology-oriented medical hyaluronic acid, the product in 2019 accounted for 45% of revenue.
4 Yuexin Health (002162): its wholly-owned Shanghai Yuexin Comprehensive Outpatient Clinic has been approved by the Shanghai Municipal Health Commission to have the operating qualifications of cosmetic surgery, cosmetic dermatology, and can carry out first- and second-degree cosmetic surgery.
5CHANGSHAN PHARMACEUTICALS (300255): Subsidiary Hebei Changshan Kelonite Biotechnology Co., Ltd. is mainly engaged in the research and development, production and sales of hyaluronic acid (hyaluronic acid) and its series of products.
6 East China Pharmaceutical (000963): Holding subsidiary East China Ningbo Company is a comprehensive medical aesthetic big health platform company that integrates medical aesthetic product research and development, production, sales and personalized customized service. Its British medical aesthetic company Sinclair as a globalized operation of medical aesthetic company, its business covers the whole industry chain from R & D, production, sales, etc. Existing products include long-lasting microspheres and cosmetic buried threads.
The above is the introduction of several stocks in the medical aesthetic sector, I hope it will help you.